HDAC9 and cancer: Consistent with this, a recent systematic review of pan-HDAC inhibitors in cancer patients demonstrated mild cardiac side effects that included ST-segment and T wave (ST/T) abnormalities along with QT prolongation; this is a concern, as these measures demonstrate the potential for lethal ventricular arrhythmias [117].